Dexcom Inc
XETRA:DC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dexcom Inc
XETRA:DC4
|
US |
|
Cannabist Company Holdings Inc
OTC:CBSTF
|
US |
|
G
|
Globe Life Inc
XBER:TMJ
|
US |
|
Old Second Bancorp Inc
NASDAQ:OSBC
|
US |
|
R
|
Renesas Electronics Corp
OTC:RNECF
|
JP |
|
DENTSPLY SIRONA Inc
F:DY2
|
US |
|
E
|
East Japan Railway Co
SWB:EJR
|
JP |
|
M
|
MicroVision Inc
F:MVIN
|
US |
Wall St Price Targets
DC4 Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DC4 is 77.12 EUR with a low forecast of 67.98 EUR and a high forecast of 105.53 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DC4's stock price target?
Price Target
77.12
EUR
According to Wall Street analysts, the average 1-year price target for DC4 is 77.12 EUR with a low forecast of 67.98 EUR and a high forecast of 105.53 EUR.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Dexcom Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
20%
The compound annual growth rate for Operating Income over the next 3 years is 20%.
What is the Pre-Tax Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 3 years is 19%.
